健康效用值映射法转换的研究现状
|
摘要
目的系统综述国内外健康效用普适性量表与疾病专属性量表之间以及普适性量表之间运用映射法进行结果转换的研究文献,为该领域研究提供可资借鉴的方法和科学依据。方法检索于2007—2018年发表在Springer、中国期刊全文数据库、中文期刊全文数据库和万方数据知识服务平台等中英文数据库中的发表有关映射法在健康效用值测量应用研究的相关文献,汇总并整理。结果共计检索出958篇中英文文献,通过排除筛选,纳入50篇符合要求的研究文献,按照具有明确函数关系、未有明确函数关系、疾病特异性量表与普适性量表之间的映射、普适性量表之间的映射四个方面进行分析总结。结论对研究量表的选取应综合考虑各量表的特点和适用性,拓宽研究量表的选取种类;多数研究的最佳映射模型为OLS(最小二乘法)回归结果,对新型回归方法的应用较少,学者应以多种回归方法构建映射模型,进行性能对比;目前研究的样本量较少,研究结果可信度不高。应加大样本量,并在映射模型的构建中建立多个回归模型以检验不同指标变量组合的模型性能;研究范围应进一步扩展,对不同年龄、不同性别的人群等进行研究。对普通疾病的相关研究较少,应在普通疾病的映射研究领域多进行探索。
Objective To systematically review domestic and foreign research literature on applying mapping method to transform health utility values between health utility universal scales themselves or universal scales and the disease-specific scales, so as to provide advisable methods and scientific basis for research in this area. Methods Through relevant literature study and collect which were published in Springer.com, CNKI, Weip Database and Wanfang Database and other Chinese and Western database during 2007—2018. Results A total of 958 Chinese and English documents were retrieved, and 50 research documents that met the requirements were included in the screening. The following four aspects were analyzed: a clear functional relationship, no clear functional relationship, disease-specific scale and universality. Mapping between sex scales and mapping between universal scales. Conclusion Scholars should consider the characteristics and applicability of each scale comprehensively when selecting the research scale, and broaden the selection of research scales; the best mapping model for most studies is the OLS(Ordinary least squares)regression result, there are few applications of new regression methods, so scholars should construct mapping models with multiple regression methods and compare their performance; the sample size of the research is relatively small, and the reliability of the research results is not high. Therefore, multiple regression models should be established to test the performance of different index variable combinations in the construction of mapping models; the scope of the study should be expanded to include people of different ages and genders. There are few researches on common diseases, so the mapping research on common diseases should be explored more.
Objective To systematically review domestic and foreign research literature on applying mapping method to transform health utility values between health utility universal scales themselves or universal scales and the disease-specific scales, so as to provide advisable methods and scientific basis for research in this area. Methods Through relevant literature study and collect which were published in Springer.com, CNKI, Weip Database and Wanfang Database and other Chinese and Western database during 2007—2018. Results A total of 958 Chinese and English documents were retrieved, and 50 research documents that met the requirements were included in the screening. The following four aspects were analyzed: a clear functional relationship, no clear functional relationship, disease-specific scale and universality. Mapping between sex scales and mapping between universal scales. Conclusion Scholars should consider the characteristics and applicability of each scale comprehensively when selecting the research scale, and broaden the selection of research scales; the best mapping model for most studies is the OLS(Ordinary least squares)regression result, there are few applications of new regression methods, so scholars should construct mapping models with multiple regression methods and compare their performance; the sample size of the research is relatively small, and the reliability of the research results is not high. Therefore, multiple regression models should be established to test the performance of different index variable combinations in the construction of mapping models; the scope of the study should be expanded to include people of different ages and genders. There are few researches on common diseases, so the mapping research on common diseases should be explored more.
引文
[1]付希婧,梁敏洪,孙茂,等.映射法在健康效用值测量中的应用研究[J].中国卫生经济,2014,33(10):32-35.
[2]Brazier JE,Yang Y,Tsuchiya A,et al.A review of studies mapping(or cross walking)from non-preference based measures of health to generic preference-based measures[J].Eur J Health Econ,2010,11(2):215-225.
[3]Chen G,Iezzi A,McKie J,et al.Diabetes and quality of life:Comparing results from utility instruments and Diabetes-39[J].Diabetes res clin pract,2015,109(2):326-333.(http://dx.doi.org/10.1016/j.diabres.2015.05.011).
[4]Barton GR,Sach TH,Jenkinson C,et al.Michael Doherty and Kenneth R Muir.Do estimates of cost-utility based on the EQ-5Ddiffer from those based on the mapping of utility scores?[J].Health Qual Life Outcomes,2008(6):51.(http://www.hqlo.com/content/6/1/51)
[5]Xie F,Pullenayegum EM,Li SC,et al.Use of a Disease-Specific Instrument in Economic Evaluations:Mapping WOMAC onto the EQ-5D Utility Index[J].Value Health,2010,13(8):873-878.
[6]Bilbao A,Martín-Fernández J,García-Perez L,et al.Mapping From The Womac To The EQ-5D-5L Questionnaire:Comparison Of Different Methodologies[J].Value in Health,2017,20(9):755.
[7]Askew RL,Swartz RJ,Xing Y,et al.Mapping FACT-Melanoma Quality-of-Life Scores to EQ-5D Health Utility Weights[J].Value Health,2011,14(6):900-906.
[8]Wu EQ,Mulani P,Farrell MH,et al.Mapping FACT-P and EORTCQLQ-C30 to patient health status measured by EQ-5D in metastatic hormonerefractory prostate cancer patients[J].Value Health,2007,10(5):408-414.
[9]Cella D,Proskorovsky I,Pan F.Approach to Fixing the Discrepancy Found in the Wu et al.FACT-P to EQ-5D Questionnaire Mapping Algorithm[J].Value In Health,2012,15(5):783-784.(http://dx.doi.org/10.1016/j.jval.2012.01.011).
[10]Buxton MJ,BA,Lacey LA,Feagan BG,et al.Mapping from DiseaseSpecific Measures to Utility:An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn’s Disease Activity Index in Crohn’s Disease and Measures of Utility[J].Value Health,2007,10(3):214-220.
[11]Sauerland S,Weiner S,Dolezalova K,et al.Mapping Utility Scores from a Disease-Specific Quality-of-Life Measure in Bariatric Surgery Patients[J].Value Health,2009,12(2):364-370.
[12]Starkie HJ,Briggs AH,Chambers MG,et al.Predicting EQ-5DValues Using the SGRQ[J].Value Health,2011,14(2):354-360.
[13]Hoyle CK,Tabberer M,Brooks J.Mapping the COPD Assessment Test onto EQ-5D[J].Value Health,2016,19(4):469-477.
[14]Maria Ko?towska-H?ggstr?m MD,Bj?rn Jonsson PhD,Dag Isacson PhD,et al.Using EQ-5D to Derive General Population-based Utilities forthe Quality of Life Assessment of Growth Hormone Deficiency in Adults(QoL-AGHDA)[J].Value in health,2007,10(1):73-81.
[15]Lindkvist M,Feldman I.Assessing outcomes for cost-utility analysis in mental health interventions:mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L[J].Health Qual Life Outcomes,2016,14(1):134.
[16]Pulay AJ,Bitter I,Papp S,et al.Exploring the Relationship between Quality of Life(EQ-5D)and ClinicalMeasures in Adult Attention Deficit Hyperactivity Disorder(ADHD)[J].Applied Research Quality Life,2017,12(2):409-424.
[17]Blome C,Beikert FC,Rustenbach SJ,et al.Mapping DLQI on EQ-5D in psoriasis:transformation of skin-specific health-related quality of life into utilities[J].Arch Dermatol Res,2013,305(3):197-204.
[18]Meacock R,Harrison M,McElhone K,et al.Mapping the diseasespecific LupusQoL to the SF-6D[J].Qual Life Res,2015,24(7):1749-1758.
[19]Badia X,Roset M,Valassi E.Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing’s syndrome(ERCUSYN)[J].Qual Life Res,2013,22(10):2941-2950.
[20]Herédi E,Rencz F,Balogh O,et al.Exploring the relationship between EQ-5D,DLQI and PASI,and mapping EQ-5D utilities:a cross-sectional study in psoriasis from Hungary[J].Eur J Health Econ,2014,15(1):111-119.
[21]Hua AY,Westin O,Hamrin Senorski E,et al.Mapping functions in health-related quality of life:mapping from the Achilles Tendon Rupture Score to the EQ-5D[J].Knee Surg Sports Traumatol Arthrosc,2018,26(10):3083-3088.(https://doi.org/10.1007/s00167-018-4954-y)
[22]Zheng Y,Tang K,Ye L,et al.Mapping the neck disability index to SF-6D in patients with chronic neck pain[J].Health Qual Life Outcomes,2016(14):21.
[23]Chen G,Tan JT,Ng K.Mapping of Incontinence Quality of Life(I-QOL)scores to Assessment of Quality of Life 8D(AQoL-8D)utilities in patients with idiopathic overactive bladder[J].Health Qual Life Outcomes,2014(12):133.(http://www.hqlo.com/content/12/1/133).
[24]Hatswell AJ,Vegter S.Measuring quality of life in opioid-induced constipation:mapping EQ-5D-3 L and PAC-QOL[J].Health Econ Rev,2016,6(1):14.
[25]Parker M,Haycox A,Graves J.Estimating the relationship between preferencebased generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation:challenges in practice[J].Pharmacoeconomics,2011,29(8):719-730.
[26]Cheung YB,Tan LC,Lau PN,et al.Mapping the eight-item Parkinson’s Disease Questionnaire(PDQ-8)to the EQ-5D utility index[J].Qual Life Res,2008,17(9):1173-1181.
[27]Badia X,Trainer P,Biermasz NR,et al.Mapping Acroqol Scores to EQ-5D to obtain Utility values for patients with acromegaly[J].JMed Econ,2018,21(4):382-389.
[28]Wong CKH,Cheung PWH,Samartzis D,et al.Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis[J].PLoS One,2017,12(4):e0175847.
[29]Chen G,Stevens K,Rowen D,et al.From KIDSCREEN-10 to CHU9D:creating a unique mapping algorithm for application in economic evaluation[J].Health Qual Life Outcomes,2014(12):134.(http://www.hqlo.com/content/12/1/134).
[30]Dakin H,Petrou S,Haggard M,et al.Mapping analyses to estimate health utilities based on responses to the OM8-30 otitis media questionnaire[J].Qual Life Res,2010,19(1):65-80.
[31]付希婧.映射法在健康效用值测量中的应用研究[D].北京:北京中医药大学,2015.
[32]Ara R,Brazier J.Deriving an Algorithm to Convert the Eight Mean SF-36 Dimension Scores into a Mean EQ-5D Preference-Based Score from Published Studies(Where Patient Level Data Are Not Available)[J].Value Health,2008,(11)7:1131-1143.
[33]Carre?o A,BSc,Fernández I,Badia X,et al.Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain[J].Value Health,2011,14(1):192-200.
[34]Cheung YB,Thumboo J,Gao F,et al.Mapping the English and Chinese Versions of the Functional Assessment of Cancer TherapyGeneral to the EQ-5D utility index[J].Value health,2009,12(2):371-376.
[35]Kim SH,Jo MW,Kim HJ,et al.Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients[J].Health Qual Life Outcomes,2012(10):151.(http://www.hqlo.com/content/10/1/151).
[36]Kim EJ,Ko SK,Kang HY.Mapping the cancer-specific EORTCQLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients[J].Qual Life Res,2012,21(7):1193-1203.
[37]Kontodimopoulos N.The potential for a generally applicable mapping model between QLQ-C30 and SF-6D in patients with different cancers:a comparison of regression-based methods[J].Qual Life Res,2015,24(6):1535-1544.
[38]Kalaitzakis E,Benito de Valle M,Rahman M,et al.Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis[J].Qual Life Res,2016,25(4):947-957.
[39]Ali FM,Kay R,Finlay AY,et al.Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression[J].Qual Life Res,2017,26(11):3025-3034.
[40]Proskorovsky I,Lewis P,Williams CD,et al.Mapping EORTCQLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma[J].Health Qual Life Outcomes,2014(12):35.(http://www.hqlo.com/content/12/1/35).
[41]Acaster S,Pinder B,Mukuria C,et al.Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approaches[J].Health Qual Life Outcomes,2015(13):33.
[42]Yang Y,Wong MY,Lam CL,et al.Improving the mapping of condition-specific health-related quality of life onto SF-6D score[J].Qual Life Res,2014,23(8):2343-2353.
[43]Dixon P,Dakin H,Wordsworth S.Generic and disease-specific estimates of quality of life in macular degeneration:mapping the MacDQoL onto the EQ-5D-3L[J].Qual Life Res,2016,25(4):935-945.
[44]Gillard PJ,Devine B,Varon SF,et al.Mapping from DiseaseSpecific Measures to Health-State Utility Values in Individuals with Migraine[J].Value Health,2012,15(3):485-494.
[45]Wijnen BFM,Mosweu I,Majoie MHJM,et al.A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy[J].Eur J Health Econ,2018,19(6):861-870.
[46]Pinedo-Villanueva RA,Turner D,Judge A,et al.Mapping the Oxford hip score onto the EQ-5D utility index[J].Qual Life Res,2013,22(3):665-675.
[47]Gu NY,Botteman MF,Ji X,et al.Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities[J].Health Qual Life Outcomes,2011(9):119.(http://www.hqlo.com/content/9/1/119).
[48]Ghatnekar O,Eriksson M,Glader EL.Mapping health outcome measures from a stroke registry to EQ-5D weights[J].Health Quality Life Outcomes,2013(11):34.(http://www.hqlo.com/content/11/1/34).
[49]Collado-Mateo D,Chen G,Garcia-Gordillo MA,et al.“Fibromyalgia and quality of life:mapping the revised fibromyalgia impact questionnaire to the preference-based instruments”[J].Health Qual Life Outcomes,2017,15(1):114.
[50]Le QA.Probabilistic mapping of the health status measure SF-12onto the health utility measure EQ-5D using the US-population-based scoring models[J].Qual Life Res,2014,23(2):459-466.
[51]Rowen D,Brazier J,Roberts J.Mapping SF-36 onto the EQ-5Dindex:how reliable is the relationship?[J]Health Qual Life Outcomes,2009(7):27.(http://www.hqlo.com/content/7/1/27).
[52]Kim SH,Kim SO,Lee SI,et al.Deriving a mapping algorithm for converting SF-36 scores to EQ-5D utility score in a Korean population[J].Health Qual Life Outcomes,2014(12):145.(http://www.hqlo.com/content/12/1/145).
[53]XU Han,HUANG Wei-dong,LIU Guo-xiang,et al.Measurement Method of Utility Value in Cost-utility Analysis[J].Chinese Health Economics,2016(1):28-30.
[54]Tscuhiya A,Brazier J,McColl E,et al.Deriving preference-based single indices from non-preference based condition-specific instruments:converting AQLQ into EQ-5D indices[J].Mpra Paper,2002.
[2]Brazier JE,Yang Y,Tsuchiya A,et al.A review of studies mapping(or cross walking)from non-preference based measures of health to generic preference-based measures[J].Eur J Health Econ,2010,11(2):215-225.
[3]Chen G,Iezzi A,McKie J,et al.Diabetes and quality of life:Comparing results from utility instruments and Diabetes-39[J].Diabetes res clin pract,2015,109(2):326-333.(http://dx.doi.org/10.1016/j.diabres.2015.05.011).
[4]Barton GR,Sach TH,Jenkinson C,et al.Michael Doherty and Kenneth R Muir.Do estimates of cost-utility based on the EQ-5Ddiffer from those based on the mapping of utility scores?[J].Health Qual Life Outcomes,2008(6):51.(http://www.hqlo.com/content/6/1/51)
[5]Xie F,Pullenayegum EM,Li SC,et al.Use of a Disease-Specific Instrument in Economic Evaluations:Mapping WOMAC onto the EQ-5D Utility Index[J].Value Health,2010,13(8):873-878.
[6]Bilbao A,Martín-Fernández J,García-Perez L,et al.Mapping From The Womac To The EQ-5D-5L Questionnaire:Comparison Of Different Methodologies[J].Value in Health,2017,20(9):755.
[7]Askew RL,Swartz RJ,Xing Y,et al.Mapping FACT-Melanoma Quality-of-Life Scores to EQ-5D Health Utility Weights[J].Value Health,2011,14(6):900-906.
[8]Wu EQ,Mulani P,Farrell MH,et al.Mapping FACT-P and EORTCQLQ-C30 to patient health status measured by EQ-5D in metastatic hormonerefractory prostate cancer patients[J].Value Health,2007,10(5):408-414.
[9]Cella D,Proskorovsky I,Pan F.Approach to Fixing the Discrepancy Found in the Wu et al.FACT-P to EQ-5D Questionnaire Mapping Algorithm[J].Value In Health,2012,15(5):783-784.(http://dx.doi.org/10.1016/j.jval.2012.01.011).
[10]Buxton MJ,BA,Lacey LA,Feagan BG,et al.Mapping from DiseaseSpecific Measures to Utility:An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn’s Disease Activity Index in Crohn’s Disease and Measures of Utility[J].Value Health,2007,10(3):214-220.
[11]Sauerland S,Weiner S,Dolezalova K,et al.Mapping Utility Scores from a Disease-Specific Quality-of-Life Measure in Bariatric Surgery Patients[J].Value Health,2009,12(2):364-370.
[12]Starkie HJ,Briggs AH,Chambers MG,et al.Predicting EQ-5DValues Using the SGRQ[J].Value Health,2011,14(2):354-360.
[13]Hoyle CK,Tabberer M,Brooks J.Mapping the COPD Assessment Test onto EQ-5D[J].Value Health,2016,19(4):469-477.
[14]Maria Ko?towska-H?ggstr?m MD,Bj?rn Jonsson PhD,Dag Isacson PhD,et al.Using EQ-5D to Derive General Population-based Utilities forthe Quality of Life Assessment of Growth Hormone Deficiency in Adults(QoL-AGHDA)[J].Value in health,2007,10(1):73-81.
[15]Lindkvist M,Feldman I.Assessing outcomes for cost-utility analysis in mental health interventions:mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L[J].Health Qual Life Outcomes,2016,14(1):134.
[16]Pulay AJ,Bitter I,Papp S,et al.Exploring the Relationship between Quality of Life(EQ-5D)and ClinicalMeasures in Adult Attention Deficit Hyperactivity Disorder(ADHD)[J].Applied Research Quality Life,2017,12(2):409-424.
[17]Blome C,Beikert FC,Rustenbach SJ,et al.Mapping DLQI on EQ-5D in psoriasis:transformation of skin-specific health-related quality of life into utilities[J].Arch Dermatol Res,2013,305(3):197-204.
[18]Meacock R,Harrison M,McElhone K,et al.Mapping the diseasespecific LupusQoL to the SF-6D[J].Qual Life Res,2015,24(7):1749-1758.
[19]Badia X,Roset M,Valassi E.Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing’s syndrome(ERCUSYN)[J].Qual Life Res,2013,22(10):2941-2950.
[20]Herédi E,Rencz F,Balogh O,et al.Exploring the relationship between EQ-5D,DLQI and PASI,and mapping EQ-5D utilities:a cross-sectional study in psoriasis from Hungary[J].Eur J Health Econ,2014,15(1):111-119.
[21]Hua AY,Westin O,Hamrin Senorski E,et al.Mapping functions in health-related quality of life:mapping from the Achilles Tendon Rupture Score to the EQ-5D[J].Knee Surg Sports Traumatol Arthrosc,2018,26(10):3083-3088.(https://doi.org/10.1007/s00167-018-4954-y)
[22]Zheng Y,Tang K,Ye L,et al.Mapping the neck disability index to SF-6D in patients with chronic neck pain[J].Health Qual Life Outcomes,2016(14):21.
[23]Chen G,Tan JT,Ng K.Mapping of Incontinence Quality of Life(I-QOL)scores to Assessment of Quality of Life 8D(AQoL-8D)utilities in patients with idiopathic overactive bladder[J].Health Qual Life Outcomes,2014(12):133.(http://www.hqlo.com/content/12/1/133).
[24]Hatswell AJ,Vegter S.Measuring quality of life in opioid-induced constipation:mapping EQ-5D-3 L and PAC-QOL[J].Health Econ Rev,2016,6(1):14.
[25]Parker M,Haycox A,Graves J.Estimating the relationship between preferencebased generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation:challenges in practice[J].Pharmacoeconomics,2011,29(8):719-730.
[26]Cheung YB,Tan LC,Lau PN,et al.Mapping the eight-item Parkinson’s Disease Questionnaire(PDQ-8)to the EQ-5D utility index[J].Qual Life Res,2008,17(9):1173-1181.
[27]Badia X,Trainer P,Biermasz NR,et al.Mapping Acroqol Scores to EQ-5D to obtain Utility values for patients with acromegaly[J].JMed Econ,2018,21(4):382-389.
[28]Wong CKH,Cheung PWH,Samartzis D,et al.Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis[J].PLoS One,2017,12(4):e0175847.
[29]Chen G,Stevens K,Rowen D,et al.From KIDSCREEN-10 to CHU9D:creating a unique mapping algorithm for application in economic evaluation[J].Health Qual Life Outcomes,2014(12):134.(http://www.hqlo.com/content/12/1/134).
[30]Dakin H,Petrou S,Haggard M,et al.Mapping analyses to estimate health utilities based on responses to the OM8-30 otitis media questionnaire[J].Qual Life Res,2010,19(1):65-80.
[31]付希婧.映射法在健康效用值测量中的应用研究[D].北京:北京中医药大学,2015.
[32]Ara R,Brazier J.Deriving an Algorithm to Convert the Eight Mean SF-36 Dimension Scores into a Mean EQ-5D Preference-Based Score from Published Studies(Where Patient Level Data Are Not Available)[J].Value Health,2008,(11)7:1131-1143.
[33]Carre?o A,BSc,Fernández I,Badia X,et al.Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain[J].Value Health,2011,14(1):192-200.
[34]Cheung YB,Thumboo J,Gao F,et al.Mapping the English and Chinese Versions of the Functional Assessment of Cancer TherapyGeneral to the EQ-5D utility index[J].Value health,2009,12(2):371-376.
[35]Kim SH,Jo MW,Kim HJ,et al.Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients[J].Health Qual Life Outcomes,2012(10):151.(http://www.hqlo.com/content/10/1/151).
[36]Kim EJ,Ko SK,Kang HY.Mapping the cancer-specific EORTCQLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients[J].Qual Life Res,2012,21(7):1193-1203.
[37]Kontodimopoulos N.The potential for a generally applicable mapping model between QLQ-C30 and SF-6D in patients with different cancers:a comparison of regression-based methods[J].Qual Life Res,2015,24(6):1535-1544.
[38]Kalaitzakis E,Benito de Valle M,Rahman M,et al.Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis[J].Qual Life Res,2016,25(4):947-957.
[39]Ali FM,Kay R,Finlay AY,et al.Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression[J].Qual Life Res,2017,26(11):3025-3034.
[40]Proskorovsky I,Lewis P,Williams CD,et al.Mapping EORTCQLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma[J].Health Qual Life Outcomes,2014(12):35.(http://www.hqlo.com/content/12/1/35).
[41]Acaster S,Pinder B,Mukuria C,et al.Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approaches[J].Health Qual Life Outcomes,2015(13):33.
[42]Yang Y,Wong MY,Lam CL,et al.Improving the mapping of condition-specific health-related quality of life onto SF-6D score[J].Qual Life Res,2014,23(8):2343-2353.
[43]Dixon P,Dakin H,Wordsworth S.Generic and disease-specific estimates of quality of life in macular degeneration:mapping the MacDQoL onto the EQ-5D-3L[J].Qual Life Res,2016,25(4):935-945.
[44]Gillard PJ,Devine B,Varon SF,et al.Mapping from DiseaseSpecific Measures to Health-State Utility Values in Individuals with Migraine[J].Value Health,2012,15(3):485-494.
[45]Wijnen BFM,Mosweu I,Majoie MHJM,et al.A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy[J].Eur J Health Econ,2018,19(6):861-870.
[46]Pinedo-Villanueva RA,Turner D,Judge A,et al.Mapping the Oxford hip score onto the EQ-5D utility index[J].Qual Life Res,2013,22(3):665-675.
[47]Gu NY,Botteman MF,Ji X,et al.Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities[J].Health Qual Life Outcomes,2011(9):119.(http://www.hqlo.com/content/9/1/119).
[48]Ghatnekar O,Eriksson M,Glader EL.Mapping health outcome measures from a stroke registry to EQ-5D weights[J].Health Quality Life Outcomes,2013(11):34.(http://www.hqlo.com/content/11/1/34).
[49]Collado-Mateo D,Chen G,Garcia-Gordillo MA,et al.“Fibromyalgia and quality of life:mapping the revised fibromyalgia impact questionnaire to the preference-based instruments”[J].Health Qual Life Outcomes,2017,15(1):114.
[50]Le QA.Probabilistic mapping of the health status measure SF-12onto the health utility measure EQ-5D using the US-population-based scoring models[J].Qual Life Res,2014,23(2):459-466.
[51]Rowen D,Brazier J,Roberts J.Mapping SF-36 onto the EQ-5Dindex:how reliable is the relationship?[J]Health Qual Life Outcomes,2009(7):27.(http://www.hqlo.com/content/7/1/27).
[52]Kim SH,Kim SO,Lee SI,et al.Deriving a mapping algorithm for converting SF-36 scores to EQ-5D utility score in a Korean population[J].Health Qual Life Outcomes,2014(12):145.(http://www.hqlo.com/content/12/1/145).
[53]XU Han,HUANG Wei-dong,LIU Guo-xiang,et al.Measurement Method of Utility Value in Cost-utility Analysis[J].Chinese Health Economics,2016(1):28-30.
[54]Tscuhiya A,Brazier J,McColl E,et al.Deriving preference-based single indices from non-preference based condition-specific instruments:converting AQLQ into EQ-5D indices[J].Mpra Paper,2002.